Menu

CERo Therapeutics Holdings, Inc. CERO

Full chart Compare
Set alert

Price alert · CERO

All alert types
0.00 USD 0.00 (+2.94%)

Nov 9, 2026, 9:53 AM EST

0.0035 Day range 0.0035
0.003 52-week range 0.135
YTD
-94.78%
1 year
-96.57%

Revenue & Expenses

Other Income → Expenses: $596.00KExpenses → Selling, General & Admin: $5.42MExpenses → Other Operating Expenses: $34.76MExpenses → Income Tax: $2.28MGross Profit → Expenses: $20.22MRevenue → Gross Profit: $20.22MNet Loss → Expenses: $21.65MOther Income$596.00KGross Profit$20.22MNet Loss$21.65MExpenses$42.47MSelling, General & Admin$5.42MOther Operating Expenses$34.76MIncome Tax$2.28MRevenue$20.22M

Latest period ending Dec 31, 2024 · select a line to chart its full history

CERO annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
-15.30M-7.68M-11.97M-11.62M-19.96M
-7.73M-7.29M-11.83M-10.63M-21.65M
-363.00-24,973.00-2,640.00-2,360.00-2.13
CERO annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
3.33M1.60M6.82M19.22M4.14M
6.21M5.13M11.35M24.18M16.64M
8.10M5.08M4.12M5.50M5.51M
1.58M2.94M3.02M3.60M0
-1.89M-42.06M-34.87M-23.43M11.13M
CERO annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
-12.28M-5.79M-11.71M-10.09M-133.00K
13.73M571.68K5.63K60.26K40.00K
1.45M-5.22M-12.40M-10.65M-946.00K